These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28466392)

  • 1. Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.
    Weitzel KW; Cavallari LH; Lesko LJ
    Pharm Res; 2017 Aug; 34(8):1551-1555. PubMed ID: 28466392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.
    Roden DM; Van Driest SL; Mosley JD; Wells QS; Robinson JR; Denny JC; Peterson JF
    Clin Pharmacol Ther; 2018 May; 103(5):787-794. PubMed ID: 29377064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
    Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
    Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stepwise approach to implementing pharmacogenetic testing in the primary care setting.
    Weitzel KW; Duong BQ; Arwood MJ; Owusu-Obeng A; Abul-Husn NS; Bernhardt BA; Decker B; Denny JC; Dietrich E; Gums J; Madden EB; Pollin TI; Wu RR; Haga SB; Horowitz CR
    Pharmacogenomics; 2019 Oct; 20(15):1103-1112. PubMed ID: 31588877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to Transition from Single-Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial.
    Marrero RJ; Cicali EJ; Arwood MJ; Eddy E; DeRemer D; Ramnaraign BH; Daily KC; Jones D; Cook KJ; Cavallari LH; Wiisanen Weitzel K; Langaee T; Newsom KJ; Starostik P; Clare-Salzer MJ; Johnson JA; George TJ; Cooper-DeHoff RM
    Clin Pharmacol Ther; 2020 Sep; 108(3):557-565. PubMed ID: 32460360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
    Dias MM; Sorich MJ; Rowland A; Wiese MD; McKinnon RA
    Pharm Res; 2017 Aug; 34(8):1544-1550. PubMed ID: 28236061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands.
    Bank PCD; Swen JJ; Guchelaar HJ
    BMC Med; 2019 Jun; 17(1):110. PubMed ID: 31196067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.
    Haidar CE; Crews KR; Hoffman JM; Relling MV; Caudle KE
    Annu Rev Genomics Hum Genet; 2022 Aug; 23():449-473. PubMed ID: 35537468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacogenetics: how do we ensure a favorable future for patients?
    Wiltshire T; Dong OM
    Pharmacogenomics; 2018 Apr; 19(6):553-562. PubMed ID: 29620450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings.
    Cicali EJ; Weitzel KW; Elsey AR; Orlando FA; Vinson M; Mosley S; Smith DM; Davis R; Drum L; Estores D; Franciosi JP; Hagen MG; Jerkins GJ; Mercado ES; Nainaparampil J; Padron A; Rosenberg EI; Wright A; Schmidt SO; Mathews CA; Cavallari LH; Johnson JA
    Genet Med; 2019 Oct; 21(10):2264-2274. PubMed ID: 30926959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualizing pharmacogenomic test results in the context of the microbiome.
    Haga SB
    Per Med; 2020 Nov; 17(6):459-468. PubMed ID: 33026284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of whole-genome sequencing-based pharmacogenetic profiling.
    Caspar SM; Schneider T; Stoll P; Meienberg J; Matyas G
    Pharmacogenomics; 2021 Feb; 22(3):177-190. PubMed ID: 33517770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years.
    Borobia AM; Dapia I; Tong HY; Arias P; Muñoz M; Tenorio J; Hernández R; García García I; Gordo G; Ramírez E; Frías J; Lapunzina P; Carcas AJ
    Clin Transl Sci; 2018 Mar; 11(2):189-199. PubMed ID: 29193749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
    Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
    PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 16. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
    Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
    Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preemptively Precise: Returning and Updating Pharmacogenetic Test Results to Realize the Benefits of Preemptive Testing.
    Haidar CE; Relling MV; Hoffman JM
    Clin Pharmacol Ther; 2019 Nov; 106(5):942-944. PubMed ID: 31520409
    [No Abstract]   [Full Text] [Related]  

  • 18. Advancing precision medicine in healthcare: addressing implementation challenges to increase pharmacogenetic testing in the clinical setting.
    Dong OM; Wiltshire T
    Physiol Genomics; 2017 Jul; 49(7):346-354. PubMed ID: 28550089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics in Italy: current landscape and future prospects.
    Floris M; Moschella A; Alcalay M; Montella A; Tirelli M; Fontana L; Idda ML; ; Guarnieri P; Capasso M; Mammì C; Nicoletti P; Miozzo M
    Hum Genomics; 2024 Jul; 18(1):78. PubMed ID: 38987819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.